Skip to main content
Retour
Watch Compare

Minerva Neurosciences, Inc.

Qualité des données : 83%
NERV
Nasdaq Manufacturing Chemicals
5,51 €
▼ 0,51 € (-8,47%)
Cap. Boursière: 239,96 M
Prix
5,55 €
Cap. Boursière
239,96 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Earnings declined -20492,68% over the past year
Negative free cash flow of -13,51 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-20492,68%
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-44,76%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,87
Interest CoverageN/A

Valorisation

PE (TTM)
-0,82
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,8 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

2 analystes
Hold
Actuel
5,51 €
+31.6%
Objectif
7,25 €
7,00 €
7,25 €
7,50 €
Prévisions
P/E Prévisionnel -11,48
BPA Prévisionnel -0,48 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,48 €
-0,48 € – -0,48 €
 0,0 1
FY2026 -0,60 €
-0,60 € – -0,60 €
 0,0 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,11 € -0,64 € -481,8%
Q32025 N/A -0,36 € —
Q22025 -0,90 € -0,43 € +52,2%
Q12025 -1,07 € -0,50 € +53,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -20492,68% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -293,42 M
ROE N/A ROA -1002,96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13,51 M
ROIC -44,76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,87
Interest Coverage N/A Asset Turnover N/A
Working Capital 10,35 M Tangible Book Value -49,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,82 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5,63%
Market Cap 239,96 M Enterprise Value 227,67 M
Per Share
EPS (Diluted TTM) -34,67 Revenue / Share N/A
FCF / Share -0,31 OCF / Share -0,31
EPS CAGR (1Y) -18347,37% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 4,60%
SBC-Adj. FCF -14,69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 0,0 0,0 0,0 41,18 M
Net Income -293,42 M 1,44 M -30,01 M -32,11 M -49,91 M
EPS (Diluted) -34,67 0,19 -4,61 -6,01 -1,17
Gross Profit — — — — —
Operating Income -15,10 M -21,85 M -23,12 M -25,23 M -45,37 M
EBITDA — — — — —
R&D Expenses 5,76 M 11,90 M 12,71 M 14,65 M 32,04 M
SG&A Expenses — — — — —
D&A 5 442,0 5 442,0 5 442,0 — 16 011,0
Interest Expense — — — — —
Income Tax — — — -1,80 M -1,80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97,97 M 37,14 M 56,90 M 55,09 M 77,12 M
Total Liabilities 233,76 M 62,84 M 85,36 M 75,11 M 69,15 M
Shareholders' Equity -140,75 M -25,69 M -28,46 M -20,02 M 7,98 M
Total Debt — — — — —
Cash & Equivalents 82,30 M 21,36 M 40,91 M 36,09 M 60,76 M
Current Assets 83,10 M 22,27 M 42,00 M 40,16 M 62,20 M
Current Liabilities 2,29 M 2,84 M 3,34 M 1,38 M 2,82 M